Table 1 Patients characteristics at the cross-sectional phase visit
From: 1-year prospective real life monitoring of asthma control and quality of life in Italy
| Â | Total | Partly controlled | Uncontrolled |
|---|---|---|---|
Number of patients, n (%) | 1017 (100) | 451 (44.3) | 566 (55.7) |
Age, years, mean (SD) | 46 (15) | 45 (15) | 47 (15) |
Gender, n (%) | Â | Â | Â |
  Males | 343 (33.7) | 160 (35.5) | 183 (32.3) |
  Females | 674 (66.3) | 291 (64.5) | 383 (67.7) |
Duration of asthma, years, mean (SD) | 17.4 (13.0) | 16.4 (12.7) | 18.2 (13.2) |
Body mass index categories, n (%) | Â | Â | Â |
  Obese (≥ 30 kg/m2) (1) | 201 (19.8) | 75 (16.6) | 126 (22.3) |
  Overweight (≥ 25 and < 30 kg/m2) | 357 (35.1) | 162 (35.9) | 195 (34.5) |
  Normal weight (≥ 18.5 and < 25 kg/m2) | 390 (38.4) | 188 (41.7) | 202 (35.7) |
  Underweight (< 18.5 kg/m2) | 32 (3.2) | 12 (2.7) | 20 (3.5) |
  Not available | 37 (3.6) | 14 (3.1) | 23 (4.1) |
Smoking habits, n (%) | Â | Â | Â |
  Current smokers | 197 (19.4) | 77 (17.1) | 120 (21.2) |
  Non-smokers | 637 (62.6) | 287 (63.6) | 350 (61.8) |
  Ex-smokers (2) | 174 (17. 1) | 86 (19.1) | 88 (15.6) |
  Not available | 9 (0.9) | 1 (0.2) | 8 (1.4) |
Concomitant diseases (3), n (%) | Â | Â | Â |
  Total | 640 (62.9) | 287 (63.6) | 353 (62.4) |
  Rhinitis | 362 (35.6) | 164 (36.4) | 198 (35.0) |
  Cardiovascular diseases | 151 (14.8) | 70 (15.5) | 81 (14.3) |
  Gastro-oesophageal reflux | 171 (16.8) | 68 (15.1) | 103 (18.2) |
  Sinusitis (4) | 114 (11.2) | 38 (8.4) | 76 (13.4) |
  Nasal polyposis | 52 (5.1) | 25 (5.5) | 27 (4.8) |
  Type 2 diabetes | 39 (3.8) | 14 (3.1) | 25 (4.4) |
  Respiratory infections | 43 (4.2) | 15 (3.3) | 28 (5.0) |
  Psychological disturbances | 25 (2.5) | 9 (2.0) | 16 (2.8) |
  Type 1 diabetes | 5 (0.5) | 2 (0.4) | 3 (0.5) |
  Other diseases | 108 (10.6) | 42 (9.3) | 66 (11.7) |
Quality of life, n | 1010 | 448 | 562 |
  EQ-5D (5) score, mean (SD) | 0.72 (0.2) | 0.75 (0.2) | 0.69 (0.2) |
  EQ-5D (5) VAS score, mean (SD) | 65.1 (15.6) | 68.6 (14.9) | 61.5 (16.3) |